At the American College of Rheumatology’s (ACR) Annual Scientific Meeting in Chicago, US, Novartis will be presenting positive phase III data results on November 9 from ACZ885, a fully human monoclonal antibody that inhibits IL-1 beta.
The study suggested that 45 per cent of children with active systemic juvenile idiopathic arthritis (SJIA) were [...]
December 26, 2011 | Posted in
Steroids Blog |
Read More »
There are no differences in terms of benefits when comparisons are made between cystic fibrosis (CF) patients on inhaled corticosteroids and those who didn’t use inhaled steroids for a period of six months, as per a finding presented in an issue of the American Journal of Respiratory and Critical Care Medicine and [...]
April 20, 2010 | Posted in
Steroids Blog |
Read More »
Previous asthma management plans suggest doubling the dose of inhaled corticosteroids when asthma controls fail. In a recent study conducted in UK, a four fold increase in dosage showed that it prevented any exacerbations from occuring.
The study employed asthma patients wherein management plans include increasing their maintenance dose of beclomethasone inhaler or its equivalent. From [...]
July 23, 2009 | Posted in
Steroids Blog |
Read More »